Chimeric Natural Killer Receptor-Universal T Cells therapy(Fujian Medical University)

N/A

Report date: 2024/09/15 20:00:04

Base Information

Drug NameChimeric Natural Killer Receptor-Universal T Cells therapy(Fujian Medical University)
Drug Alias NameChimeric Natural Killer Receptor Universal T-cells (CNK-UT)therapy(Fujian Medical University)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFujian Medical University
China Registration ClassN/A

Develop Information

Active CompaniesFujian Medical University
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A